Nuclear factor-κB mediates angiogenesis and metastasis of human bladder cancer through the regulation of interleukin-8

Clinical Cancer Research

Volumn 9, Issue 7, 2003, Pages 2786-2797

  Karashima, Takashi ^a   Sweeney, Paul ^a   Kamat, Ashish ^a   Huang, Suyun ^a   Kim, Sun J ^a   Bar Eli, Menashe ^a   McConkey, David J ^a   Dinney, Colin P N ^a  

^a UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 8; TRANSCRIPTION FACTOR AP 1; DNA FRAGMENT; I KAPPA B; MESSENGER RNA; NF KAPPAB INHIBITOR ALPHA; NF-KAPPAB INHIBITOR ALPHA;

ACIDITY; ANGIOGENESIS; ARTICLE; BLADDER METASTASIS; CANCER INHIBITION; CARCINOGENICITY; CELL MUTANT; CELL PROLIFERATION; CONTROLLED STUDY; ENZYME LINKED IMMUNOSORBENT ASSAY; GEL MOBILITY SHIFT ASSAY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HYPOXIA; INTERMETHOD COMPARISON; LYMPH NODE METASTASIS; MICROENVIRONMENT; NORTHERN BLOTTING; PH MEASUREMENT; PRIORITY JOURNAL; PROTEIN EXPRESSION; TUMOR GROWTH; ANIMAL; ANOXIA; BAGG ALBINO MOUSE; BLADDER TUMOR; CANCER TRANSPLANTATION; CELL DIVISION; CELL NUCLEUS; DOWN REGULATION; GENE EXPRESSION REGULATION; GENETICS; IN SITU HYBRIDIZATION; MALE; METABOLISM; METASTASIS; MOUSE; MUTATION; NEOVASCULARIZATION (PATHOLOGY); NUDE MOUSE; PH; PHYSIOLOGY; PROTEIN BINDING; TUMOR CELL LINE; UPREGULATION; WESTERN BLOTTING;

ANIMALS; ANOXIA; BLOTTING, NORTHERN; BLOTTING, WESTERN; CELL DIVISION; CELL LINE, TUMOR; CELL NUCLEUS; DNA FRAGMENTATION; DOWN-REGULATION; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; HYDROGEN-ION CONCENTRATION; I-KAPPA B PROTEINS; IN SITU HYBRIDIZATION; INTERLEUKIN-8; LYMPHATIC METASTASIS; MALE; MICE; MICE, INBRED BALB C; MICE, NUDE; MUTATION; NEOPLASM METASTASIS; NEOPLASM TRANSPLANTATION; NEOVASCULARIZATION, PATHOLOGIC; NF-KAPPA B; PROTEIN BINDING; RNA, MESSENGER; TRANSFECTION; UP-REGULATION; URINARY BLADDER NEOPLASMS;

EID: 0037816586     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (83)

1. Matsushima, K., and Oppenheim, J. Interleukin-8 and MCAF: novel inflammatory cytokines inducible by IL-8 and TNF. Cytokine, 1: 2-12, 1989.
2. Arenberg, D. A., Kunkel, S. L., Polverini, P. J., Glass, M., Burdick, M. D., and Strieter, R. M. Inhibition of interleukin-8 reduces tumorigenesis of human non-small-cell lung cancer in SCID mice. J. Clin. Investig., 97: 2792-2802, 1996.
3. Koch, A. E., Polverini, P. J., Kunkel, S. L., Harlow, L. A., DiPietro, L. A., Elner, V. M., Elner, S. G., and Strieter, R. M. Interleukin-8 as a macrophage-derived mediator of angiogenesis. Science (Wash. DC), 258: 1798-1801, 1992.
4. Luca, M., Huang, S., Gershenwald, J. E., Singh, R. K., Reich, R., and Bar-Eli, M. Expression of interleukin-8 by human melanoma cells up-regulates MMP-2 activity and increases tumor growth and metastasis. Am. J. Pathol., 151: 1105-1113, 1997.
5. Krueger, G., Jorgensen, C., Miller, C., Schroeder, J., Sticherling, M., and Christopher, E. Effect of IL-8 on epidermal proliferation. J. Investig. Dermatol., 94: 545, 1990.
6. Strieter, R. M., Kunkel, S. L., and Showel, H. J. Endothelial cell gene expression of a neutrophil chemotactic factor by TNF-α, LPS, and IL-1β. Science (Wash. DC), 243: 1467-1469, 1988.
7. Dinney, C. P. N., Bielenberg, D. R., Perotte, P., Reich, R., Eve, B. Y., Bucana, C. D., and Fidler, I. J. Inhibition of basic fibroblast growth factor expression, angiogenesis and growth of human bladder carcinoma in mice by systemic interferon-α administration. Cancer Res., 58: 808-814, 1998.
8. Thornton, A. J., Strieter, R. M., Lindley, I., Baggiolini, M., and Kunkel, S. L. Cytokine-induced gene expression of a neutrophil chemotactic factor/IL-8 inhuman hepatocytes. J. Immunol., 144: 2609-2613, 1990.
9. Wang, C-Y., Cusack, J. C., Jr., Liu, R., and Baldwin, A. S., Jr. Control of inducible chemoresistance: enhanced anti-tumor therapy through increased apoptosis by inhibition of NF-κB. Nat. Med., 5: 412-417, 1999.
10. Dinney, C. P., Fishbeck, R., Singh, R. K., Eve, B., Pathak, S., Brown, N., Xie, B., Fan, D., Bucana, C. D., Fidler, I. J., et al. Isolation and characterization of metastatic variants from human transitional cell carcinoma passaged by orthotopic implantation in athymic nude mice. J. Urol., 154:1532-1538, 1995.
11. Smith, D. R., Polverini, P. J., Kunkel, S. L., Orringer, M. B., Whyte, R. I., Burdick, M. D., Wilke, C. A., and Strieter, R. M. Inhibition of interleukin 8 attenuates angiogenesis in bronchogenic carcinoma. J. Exp. Med., 179: 1409-1415, 1994.
12. Singh, R. K., Gutman, M., Radinsky, R., Bucana, C. D., and Fidler, I. J. Expression of interleukin-8 correlates with the metastatic potential of human melanoma cells in nude mice. Cancer Res., 54: 3242-3247, 1994.
13. Greene, G., Kitadai, Y., Pettaway, C. A., von Eschenbach, A. C., Bucana, C. D., and Fidler, I. J. Correlation of metastasis-related gene expression with metastatic potential in human prostate carcinoma cells implanted in nude mice using an in situ messenger RNA hybridization technique. Am. J. Pathol., 150: 1571-1582, 1997.
14. Izawa, J. L., Slaton, J. W., Kedar, D., Karashima, T., Perrotte, P., Czerniak, B., Grossman, H. B., and Dinney, C. P. Differential expression of progression-related genes in the evolution of superficial to invasive transitional cell carcinoma of the bladder. Oncol. Rep., 8: 9-15, 2001.
15. Inoue, K., Slaton, J. W., Kim, S. J., Perrotte, P., Eve, B. Y., Bar-Eli, M., Radinsky, R., and Dinney, C. P. Interleukin 8 expression regulates tumorigenicity and metastasis in human bladder cancer. Cancer Res., 60: 2290-2299, 2000.
16. Roebuck, K. A. Regulation of interleukin-8 gene expression. J. Interferon Cytokine Res., 19: 429-438, 1999.
17. Baeuerle, P. A., and Henkel, T. Function and activation of NF-κB in the immune system. Annu. Rev. Immunol., 12: 141-179, 1994.
18. Barnes, P. J., and Karin, M. Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N. Engl. J. Med., 336: 1066-1071, 1997.
19. Nakshatri, H., Bhat-Nakshatri, P., Martin, D. A., Goulet, R. J. Jr., and Sledge, G. W., Jr. Constitutive activation of NF-κB during progression of breast cancer to hormone-independent growth. Mol. Cell. Biol., 17: 3629-3639, 1997.
20. Wang, W., Abbruzzese, J. L., Evans, D. B., Larry, L., Cleary, K. R., and Chiao, P. J. The nuclear factor-κB RelA transcription factor is constitutively activated in human pancreatic adenocarcinoma cells. Clin. Cancer Res., 5: 119-127, 1999.
21. Baldwin, A., S. Jr. The NF-κB and IκB proteins: new discoveries and insights. Annu. Rev. Immunol., 14: 649-683, 1996.
22. Verma, I. M., Stevenson, J. K., Schwarz, E. M., Van Antwerp, D., and Miyamoto, S. Rel/NF-κB/IκB family: intimate tales of association and dissociation. Genes Dev., 9: 2723-2735, 1995.
23. Miyamoto, S., and Verma, I. M. Rel/NF-κB/IκB story. Adv. Cancer Res., 66: 255-292, 1995.
24. Baeuerle, P. A., and Baltimore, D. IκB: a specific inhibitor of the NF-κB transcription factor. Science (Wash. DC), 242: 540-546, 1988.
25. Thanos, D., and Maniatis, T. NF-κB: a lesson in family values. Cell, 80: 529-532, 1995.
26. Beraud, C., Henzel, W. J., and and Baeuerle, P. A. Involvement of regulatory and catalytic subunits of phosphoinositide 3-kinase in NF-B activation. Biochemistry, 96: 429-434, 1999.
27. Brockman, J. A., Scherer, D. C., McKinsey, T. A., Hall, S. M., Qi, X., Lee, W. Y., and Ballard, D. W. Coupling of a signal response domain in IκBα to multiple pathways for NF-κB activation. Mol. Cell. Biol., 15: 2809-2818, 1995.
28. Brown, K., Gerstberger, S., Carlson, L., Franzoso, G., and Siebenlist, U. Control of IκB-α proteolysis by site-specific, signal-induced phosphorylation. Science (Wash. DC), 267: 1485-1488, 1995.
29. Traenckner, E. B., Pahl, H. L., Henkel, T., Schmidt, K. N., Wilk, S., and Baeuerle, P. A. Phosphorylation of human IKB-α on serines 32 and 36 controls IκB-α proteolysis and NF-κB activation in response to diverse stimuli. EMBO J., 14: 2876-2883, 1995.
30. DiDonato, J., Mercurio, F., Rosette, C., Wu-Li, J., Suyang, H., Ghosh, S., and Karin, M. Mapping of the inducible IκB phosphorylation sites that signal its ubiquitination and degradation. Mol. Cell. Biol., 16: 1295-1304, 1996.
31. Huang, S., Robinson, J. B., Deguzman, A., Bucana, C. D., and Fidler, I. J. Blockade of nuclear factor-κB signaling inhibits angiogenesis and tumorigenicity of human ovarian cancer cells by suppressing expression of vascular endothelial growth factor and interleukin 8. Cancer Res., 60: 5334-5339, 2000.
32. Huang, S., Pettaway, C. A., Uehara, H., Bucana, C. D., and Fidler, I. J. Blockade of NF-κB activity in human prostate cancer cells is associated with suppression of angiogenesis, invasion, and metastasis. Oncogene, 20: 4188-4197, 2001.
33. Clifford, J. L., Sabichi, A. L., Zou, C., Yang, X., Steele, V. E., Kelloff, G. J., Lotan, R., and Lippman, S. M. Effects of novel phenylretinamides on cell growth and apoptosis in bladder cancer. Cancer Epidemiol. Biomark. Prev., 10: 391-395, 2001.
34. Aaltonen, V., Bostrom, P. J., Soderstrom, K. O., Hirvonen, O., Tuukkanen, J., Nurmi, M., Laato, M., and Peltonen, J. Urinary bladder transitional cell carcinogenesis is associated with down-regulation of NF1 tumor suppressor gene in vivo and in vitro. Am. J. Pathol., 154: 755-765, 1999.
35. Rigby, C. C., and Frankis, L. M. A human tissue culture cell line from a transitional cell tumour of the urinary bladder: growth, chromosone pattern and ultrastructure. Br. J. Cancer, 24: 746-754, 1970.
36. Elliott, A. Y., Bronson, D. L., Cervenka, J., Stein, N., and Fraley, E. E. Properties of cell lines established from transitional cell cancers of the human urinary tract. Cancer Res., 37: 1279-1289, 1977.
37. Tazaki, H., and Tachibana, M. Studies on KU-1 and KU-7 cells as an in vitro model of human transitional cell carcinoma of urinary bladder (in Japanese). Hum. Cell, 1: 78-83, 1988.
38. Matsushima, K., Morishita, K., Yoshimura, T., Lavu, S., Kobayashi, Y., Lew, W., Appella, E., Kung, H. F., Leonard, E. J., and Oppenheim, J. J. Molecular cloning of a human monocyte-derived neutrophil chemotactic factor (MDNCF) and the induction of MDNCF mRNA by interleukin 1 and tumor necrosis factor. J. Exp. Med., 167: 1883-1893, 1988.
39. Fort, P., Marty, L., Piechaczyk, M., el Sabrouty, S., Dani, C., Jeanteur, P., and Blanchard, J. M. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res., 13: 1431-1442, 1985.
40. Kitadai, Y., Bucana, C. D., Ellis, L. M., Anzai, H., Tahara, E., and Fidler, I. J. In situ mRNA hybridization technique for analysis of metastasis-related genes in human colon carcinoma cells. Am. J. Pathol., 147: 1238-1247, 1995.
41. Radinsky, R., Bucana, C. D., Ellis, L. M., Sanchez, R., Cleary, K. R., Brigati, D. J., and Fidler, I. J. A rapid colorimetric in situ messenger RNA hybridization technique for analysis of epidermal growth factor receptor in paraffin-embedded surgical specimens of human colon carcinomas. Cancer Res., 53: 937-943, 1993.
42. Inoue, K., Slaton, J. W., Perrotte, P., Davis, D. W., Bruns, C. J., Hicklin, D. J., McConkey, D. J., Sweeney, P., Radinsky, R., and Dinney, C. P. N. Paclitaxel enhances the effects of the anti-epidermal growth factor receptor monoclonal antibody ImClone C225 in mice with metastatic human bladder tansitional cell carcinoma. Clin. Cancer Res., 6: 4874-4884, 2000.
43. Vecchi, A., Garlanda, C., Lampugnani, M. G., Resnati, M., Matteucci, C., Stoppacciaro, A., Schnurch, H., Risau, W., Ruco, L., Mantovani, A., et al. Monoclonal antibodies specific for endothelial cells of mouse blood vessels. Their application in the identification of adult and embryonic endothelium. Eur. J. Cell Biol., 63: 247-254, 1994.
44. Weidner, N., Semple, J. P., Welch, W. R., and Folkman, J. Tumor angiogenesis and metastasis: correlation in invasive breast carcinoma. N. Engl. J. Med., 324: 1-8, 1991.
45. Sutherland, R. M. Tumor hypoxia and gene expression: implications for malignant progression and therapy. Acta Oncol., 37: 567-574, 1998.
46. Vaupel, P., Kallinowski, F., and Okunieff, P. Blood flow, oxygen and nutrient supply, and metabolic microenvironment of human tumors: a review. Cancer Res., 49: 6449-6465, 1989.
47. Martin, G. R., and Jain, R. K. Noninvasive measurement of interstitial pH profiles in normal and neoplastic tissue using fluorescence ratio imaging microscopy. Cancer Res., 54: 5670-5674, 1994.
48. Folkman, J. Tumor angiogenesis and tissue factor. Nat. Med., 2: 167-168, 1996.
49. 2 gradients in solid tumors in vivo: high-resolution measurements reveal a lack of correlation. Nat. Med., 3: 177-182, 1997.
50. Turner, K. J., Crew, J. P., Wykoff, C. C., Watson, P. H., Poulsom, R., Pastorek, J., Ratcliffe, P. J., Cranston, D., and Harris, A. L. The hypoxia-inducible genes VEGF and CA9 are differentially regulated in superficial versus invasive bladder cancer. Br. J. Cancer, 86: 1276-1282, 2002.
51. Xia, G., Kageyama, Y., Hayashi, T., Hyochi, N., Kawakami, S., and Kihara, K. Positive expression of HIF-2α/EPAS1 in invasive bladder cancer. Urology, 59: 774-778, 2002.
52. Onita, T., Ji, P. G., Xuan, J. W., Sakai, H., Kanetake, H., Maxwell, Ph. H., Fong, G. H., Gabril, M. Y., Moussa, M., and Chin, J. L. Hypoxia-induced, perinecrotic expression of endothelial Per-ARNT-Sim domain protein-1/hypoxia-inducible factor-2α correlates with tumor progression, vascularization, and focal macrophage infiltration in bladder cancer. Clin. Cancer Res., 8: 471-480, 2002.
53. Movsas, B., Chapman, J. D., Horwitz, E. M., Pinover, W. H., Greenberg, R. E., Hanlon, A. L., Iyer, R., and Hanks, G. E. Hypoxic regions exist in human prostate carcinoma. Urology, 53: 11-18, 1999.
54. Dachs, G. U., and Stratford, I. J. The molecular response of mammalian cells to hypoxia and the potential for exploitation in cancer therapy. Br. J. Cancer, 27 (Suppl.): S126-S132, 1996.
55. Martinez-Zaguilan, R., Seftor, E. A., Seftor, R. E., Chu, Y. W., Gillies, R. J., and Hendrix, M. J. Acidic pH enhances the invasive behavior of human melanoma cells. Clin. Exp. Metastasis, 14: 176-186, 1996.
56. Jang, A., and Hill, R. P. An examination of the effects of hypoxia, acidosis, and glucose starvation on the expression of metastasis-associated genes in murine tumor cells. Clin. Exp. Metastasis, 15: 469-483, 1997.
57. Stasi, R., Conforti, M., Del Poeta, G., Simone, M. D., Coppetelli, U., Tribalto, M., Cantonetti, M., Perrotti, A., and Venditti, A. Papa, G. Soluble factors levels in the initial staging of high-grade non-Hodgkin's lymphomas. Haematologica, 77: 518-521, 1992.
58. Yamanaka, R., Tanaka, R., Saitoh, T., and Okoshi, S. Cytokine gene expression on glioma cell lines and specimens. J. Neurooncol., 21: 243-247, 1994.
59. Green, A. R., Green, V. L., White, M. C., and Speirs, V. Expression of cytokine messenger RNA in normal and neoplastic human breast tissue: identification of interleukin-8 as a potential regulatory factor in breast tumours. Int. J. Cancer, 72: 937-941, 1997.
60. Tjiong, M. Y., van der Vange, N., ten Kate, F. J., Tjong-A-Hung, S. P., ter Schegget, J., Burger, M. P., and Out, T. A. Increased IL-6 and IL-8 levels in cervicovaginal secretions of patients with cervical cancer. Gynecol. Oncol., 73: 285-291, 1999.
61. Kunz, M., Hartmann, A., Flory, E., Toksoy, A., Koczan, D., Thiesen, H. J., Mukaida, N., Neumann, M., Rapp, U. R., Brocker, E. B., and Gillitzer, R. Anoxia-induced up-regulation of interleukin-8 in human malignant melanoma. A potential mechanism for high tumor aggressiveness. Am. J. Pathol., 155: 753-763, 1999.
62. Huang, S., DeGuzman, A., Bucana, C. D., and Fidler, I. J. Nuclear factor-κB activity correlates with growth, angiogenesis, and metastasis of human melanoma cells in nude mice. Clin. Cancer Res., 6: 2573-2581, 2000.
63. Xu, L., and Fidler, I. J. Acidic pH-induced elevation in interleukin 8 expression by human ovarian carcinoma cells. Cancer Res., 60: 4610-4116, 2000.
64. Xu, L., Xie, K., Mukaida, N., Matsushima, K., and Fidler, I. J. Hypoxia-induced elevation in interleukin-8 expression by human ovarian carcinoma cells. Cancer Res., 59: 5822-5829, 1999.
65. Davis, N., Ghosh, S., Simmons, D. L., Tempst, P., Liou, H. C., Baltimore, D., and Bose, H. R., Jr. Rel-associated pp40: an inhibitor of the rel family of transcription factors. Science (Wash. DC), 253: 1268-1271, 1991.
66. Hatada, E. N., Nieters, A., Wulczyn, F. G., Naumann, M., Meyer, R. R., Nucifora, G., McKeithan, T. W., and Scheidereit, C. The ankyrin repeat domains of the NF-κB precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-κB DNA binding. Proc. Natl. Acad. Sci. USA, 89: 2489-2493, 1992.
67. Inoue, J., Kerr, L. D., Rashid, D., Davi, S N., Bose, H. R., Jr., and Verma, I. M. Direct association of pp40/IκBβ with rel/NF-κB transcription factors: role of ankyrin repeats in the inhibition of DNA binding activity. Proc. Natl. Acad. Sci. USA, 89: 4333-4337, 1992.
68. Beg, A. A., and Baldwin, A. S., Jr. The IκB proteins: multifunctional regulators of Rel/NF-κB transcription factors. Genes Dev., 7: 2064-2070, 1993.
69. Sun, S., Elwood, J., and Greene, W. C. Both amino- and carboxylterminal sequences within IκBα regulate its inducible degradation. Mol. Cell. Biol., 16: 1058-1065, 1996.
70. Brown, K., Franzoso, G., Baldi, L., Carlson, L., Mills, L., Lin, Y. C., Gerstberger, S., and Siebenlist, U. The signal response of IκBα is regulated by transferable N- and C-terminal domains. Mol. Cell. Biol., 17: 3021-3027, 1997.
71. Haskill, S., Beg, A. A., Tompkins, S. M., Morris, J. S., Yurochko, A. D., Sampson-Johannes, A., Mondal, K., Ralph, P., and Baldwin, A. S., Jr. Characterization of an immediate-early gene induced in adherent monocytes that encodes IκB-like activity. Cell. 65: 1281-1289, 1991.
72. Rogers, S., Wells, R., and Rechsteiner, M. Amino acid sequences common to rapidly degraded proteins: the PEST hypothesis. Science (Wash. DC), 234: 364-368, 1986.
73. Barroga, C. F., Stevenson, J. K., Schwarz, E. M., and Verma, I. M. Constitutive phosphorylation of IκBα by casein kinase II. Proc. Natl. Acad. Sci. USA, 92: 7637-7641, 1995.
74. Lin, R., Beauparlant, P., Makris, C., Meloche, S., and Hiscott, J. Phosphorylation of IκBα in the C-terminal PEST domain by casein kinase II affects intrinsic protein stability. Mol. Cell. Biol., 16: 1401-1409, 19996.
75. McElhinny, J. A., Trushin, S. A., Bren, G. D., Chester, N., and Paya, C. V. Casein kinase II phosphorylates IκBα at S-283, S-289, S-293, and T-291 and is required for its degradation. Mol. Cell. Biol., 16: 899-906, 1996.
76. Schwarz, E. M., Van Antwerp, D., and Verma, I. M. Constitutive phosphorylation of IκBα by casein kinase II occurs preferentially at serine 293: requirement for degradation of free IκBα. Mol. Cell. Biol., 16: 3554-3559, 1996.
77. Andela, V. B., Schwarz, E. M., Puzas, J. E., O'Keefe, R. J., and Rosier, R. N. Tumor metastasis and the reciprocal regulation of prometastatic and antimetastatic factors by nuclear factor κB. Cancer Res., 60: 6557-6562, 2000.
78. Bonni, A., Brunet, A., West, A. E., Datta, S. R., Takasu, M. A., and Greenberg, M. E. Cell survival promoted by the Ras-MAPK signaling pathway by transcription-dependent and -independent mechanisms. Science (Wash. DC), 286: 1358-1362, 1999.
79. Datta, S. R., Brunet, A., and Greenberg, M. E. Cellular survival: a play in three Akts. Genes Dev., 13: 2905-2927, 1999.
80. Russo, S. M., Tepper, J. E., Baldwin, A. S., Jr., Liu, R., Adams, J., Elliott, P., and Cusack, J. C., Jr. Enhancement of radiosensitivity by proteasome inhibition: implications for a role of NF-κB. Int. J. Radiat. Oncol. Biol. Phys., 50: 183-193, 2001.
81. Cusack, J. C., Jr., Liu, R., Houston, M., Abendroth, K., Elliott, P. J., Adams, J., and Baldwin, A. S., Jr. Enhanced chemosensitivity to CPT-11 with proteasome inhibitor PS-341: implications for systemic nuclear factor-κB inhibition. Cancer Res., 61: 3535-3540, 2001.
82. Sunwoo, J. B., Chen, Z., Dong, G., Yeh, N., Crowl Bancroft, C., Sausville, E., Adams, J., Elliott, P., and Van Waes, C. Novel proteasome inhibitor PS-341 inhibits activation of nuclear factor-κB, cell survival, tumor growth, and angiogenesis in squamous cell carcinoma. Clin. Cancer Res., 7: 1419-1428, 2001.
83. Shah, S. A., Potter, M. W., McDade, T. P., Ricciardi, R., Perugini, R. A., Elliott, P. J., Adams, J., and Callery, M. P. 26S proteasome inhibition induces apoptosis and limits growth of human pancreatic cancer. J. Cell. Biochem., 82: 110-122, 2001.